MSNBC

Company 'Pauses' Launch of $89,000 Muscular Dystrophy Drug

MSNBC: Health - Wed, 03/01/2017 - 11:33am
A drugmaker fiven FDA approval to market a generic drug for muscular dystrophy has 'paused' rollout after an outcry over its $89,000-a-year price tag.
Categories: MSNBC

Company 'Pauses' Launch of $89,000 Muscular Dystrophy Drug

MSNBC: Health - Wed, 03/01/2017 - 11:33am
A drugmaker fiven FDA approval to market a generic drug for muscular dystrophy has 'paused' rollout after an outcry over its $89,000-a-year price tag.
Categories: MSNBC

Company 'Pauses' Launch of $89,000 Muscular Dystrophy Drug

MSNBC: Business - Wed, 03/01/2017 - 11:33am
A drugmaker fiven FDA approval to market a generic drug for muscular dystrophy has 'paused' rollout after an outcry over its $89,000-a-year price tag.
Categories: MSNBC

Company 'Pauses' Launch of $89,000 Muscular Dystrophy Drug

MSNBC: Health - Wed, 03/01/2017 - 11:33am
A drugmaker fiven FDA approval to market a generic drug for muscular dystrophy has 'paused' rollout after an outcry over its $89,000-a-year price tag.
Categories: MSNBC

Company 'Pauses' Launch of $89,000 Muscular Dystrophy Drug

MSNBC: Business - Wed, 03/01/2017 - 11:33am
A drugmaker fiven FDA approval to market a generic drug for muscular dystrophy has 'paused' rollout after an outcry over its $89,000-a-year price tag.
Categories: MSNBC

Company 'Pauses' Launch of $89,000 Muscular Dystrophy Drug

MSNBC: Health - Wed, 03/01/2017 - 11:33am
A drugmaker fiven FDA approval to market a generic drug for muscular dystrophy has 'paused' rollout after an outcry over its $89,000-a-year price tag.
Categories: MSNBC

Company 'Pauses' Launch of $89,000 Muscular Dystrophy Drug

MSNBC: Business - Wed, 03/01/2017 - 11:33am
A drugmaker fiven FDA approval to market a generic drug for muscular dystrophy has 'paused' rollout after an outcry over its $89,000-a-year price tag.
Categories: MSNBC

Company 'Pauses' Launch of $89,000 Muscular Dystrophy Drug

MSNBC: Health - Wed, 03/01/2017 - 11:33am
A drugmaker fiven FDA approval to market a generic drug for muscular dystrophy has 'paused' rollout after an outcry over its $89,000-a-year price tag.
Categories: MSNBC

Company 'Pauses' Launch of $89,000 Muscular Dystrophy Drug

MSNBC: Business - Wed, 03/01/2017 - 11:33am
A drugmaker fiven FDA approval to market a generic drug for muscular dystrophy has 'paused' rollout after an outcry over its $89,000-a-year price tag.
Categories: MSNBC

Company 'Pauses' Launch of $89,000 Muscular Dystrophy Drug

MSNBC: Health - Wed, 03/01/2017 - 11:33am
A drugmaker fiven FDA approval to market a generic drug for muscular dystrophy has 'paused' rollout after an outcry over its $89,000-a-year price tag.
Categories: MSNBC

Company 'Pauses' Launch of $89,000 Muscular Dystrophy Drug

MSNBC: Business - Wed, 03/01/2017 - 11:33am
A drugmaker fiven FDA approval to market a generic drug for muscular dystrophy has 'paused' rollout after an outcry over its $89,000-a-year price tag.
Categories: MSNBC

Company 'Pauses' Launch of $89,000 Muscular Dystrophy Drug

MSNBC: U.S. news - Wed, 03/01/2017 - 11:33am
A drugmaker fiven FDA approval to market a generic drug for muscular dystrophy has 'paused' rollout after an outcry over its $89,000-a-year price tag.
Categories: MSNBC

Company 'Pauses' Launch of $89,000 Muscular Dystrophy Drug

MSNBC: Health - Wed, 03/01/2017 - 11:33am
A drugmaker fiven FDA approval to market a generic drug for muscular dystrophy has 'paused' rollout after an outcry over its $89,000-a-year price tag.
Categories: MSNBC

Company 'Pauses' Launch of $89,000 Muscular Dystrophy Drug

MSNBC: Business - Wed, 03/01/2017 - 11:33am
A drugmaker fiven FDA approval to market a generic drug for muscular dystrophy has 'paused' rollout after an outcry over its $89,000-a-year price tag.
Categories: MSNBC

Company 'Pauses' Launch of $89,000 Muscular Dystrophy Drug

MSNBC: U.S. news - Wed, 03/01/2017 - 11:33am
A drugmaker fiven FDA approval to market a generic drug for muscular dystrophy has 'paused' rollout after an outcry over its $89,000-a-year price tag.
Categories: MSNBC

The Superman Who Was Afraid of Heights: Dean Cain on Fear

MSNBC: Top Stories - Wed, 03/01/2017 - 11:30am
Playing Superman turned out to be Dean Cain's big break, but few knew the actor's own kryptonite: The Man of Steel was afraid of heights.
Categories: MSNBC

The Superman Who Was Afraid of Heights: Dean Cain on Fear

MSNBC: Top Stories - Wed, 03/01/2017 - 11:30am
Playing Superman turned out to be Dean Cain's big break, but few knew the actor's own kryptonite: The Man of Steel was afraid of heights.
Categories: MSNBC

'No Disrespect': Conway Explains Why She Was Kneeling on WH Couch

MSNBC: U.S. news - Wed, 03/01/2017 - 11:15am
Kellyanne Conway, counselor to the president, said she had been asked to take a picture from a specific angle when she was photographed kneeling on an Oval Office couch — a pose many felt was disrespectful.
Categories: MSNBC

'No Disrespect': Conway Explains Why She Was Kneeling on WH Couch

MSNBC: Top Stories - Wed, 03/01/2017 - 11:15am
Kellyanne Conway, counselor to the president, said she had been asked to take a picture from a specific angle when she was photographed kneeling on an Oval Office couch — a pose many felt was disrespectful.
Categories: MSNBC

'No Disrespect': Conway Explains Why She Was Kneeling on WH Couch

MSNBC: U.S. news - Wed, 03/01/2017 - 11:15am
Kellyanne Conway, counselor to the president, said she had been asked to take a picture from a specific angle when she was photographed kneeling on an Oval Office couch — a pose many felt was disrespectful.
Categories: MSNBC
Syndicate content